Published in J Gen Intern Med on December 01, 2003
Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study. BMC Cardiovasc Disord (2004) 0.98
Predictors of healthcare professionals' intention and behaviour to encourage physical activity in patients with cardiovascular risk factors. BMC Public Health (2011) 0.81
Understanding and modifying physician behavior for prevention and management of cardiovascular disease. J Gen Intern Med (2003) 0.78
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA (1999) 40.60
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Why we need observational studies to evaluate the effectiveness of health care. BMJ (1996) 17.27
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med (1987) 13.50
Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med (2002) 5.80
The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA (1984) 5.65
The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med (2000) 3.93
Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med (1995) 3.29
Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care (1998) 2.47
Getting cardiologists interested in lipids. Am J Cardiol (1993) 2.20
Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events. Am J Cardiol (2003) 2.06
Use and monitoring of "statin" lipid-lowering drugs compared with guidelines. Arch Intern Med (2001) 1.93
Psychologic effects of the diagnosis and treatment of hypercholesterolemia: lessons from case studies. Am J Med (1991) 1.65
Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S) Lancet (1995) 1.63
Health promotion: physicians' beliefs, attitudes, and practices. Am J Prev Med (1988) 1.57
Cost-effectiveness comparisons using "real world" randomized trials: the case of new antidepressant drugs. J Clin Epidemiol (1995) 1.49
Preventive practices by physicians: behavioral determinants and potential interventions. Am J Prev Med (1988) 1.44
Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease. Arch Intern Med (1998) 1.42
Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol (1999) 1.21
Physician-based diet counseling for cholesterol reduction: current practices, determinants, and strategies for improvement. Prev Med (1993) 1.13
Cholesterol risk management: a systematic examination of the gap from evidence to practice. Pharmacotherapy (2001) 1.10
Nutrition counseling in private practice: attitudes and activities of family physicians. Prev Med (1984) 1.05
A community-wide survey of physician practices and attitudes toward cholesterol management in patients with recent acute myocardial infarction. Arch Intern Med (2002) 0.99
Management of high blood cholesterol by primary care physicians: diffusion of the National Cholesterol Education Program Adult Treatment Panel guidelines. J Gen Intern Med (1990) 0.94
Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol > 125 mg/dl. Am J Cardiol (1998) 0.90
The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. Am J Cardiol (1997) 0.90
Physicians' knowledge, attitudes, and practice of pharmacologic treatment of hypertension. Ann Pharmacother (2001) 0.87
Evidence in upheaval: incorporating observational data into clinical practice. Arch Intern Med (2002) 0.84
Barriers to following National Cholesterol Educational Program guidelines. An appraisal of poor physician compliance. Arch Intern Med (1992) 0.84
Cholesterol treatment practices of primary care physicians. Public Health Rep (1992) 0.83
Controversial beliefs about diabetes and its care. Diabetes Care (1992) 0.82
Development of diabetes attitude scale for health-care professionals. Diabetes Care (1989) 0.78
Blood cholesterol treatment attitudes of community physicians: a major problem. Am Heart J (1988) 0.78
Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA (2002) 2.58
Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy. J Manag Care Pharm (2006) 2.24
Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events. Am J Cardiol (2003) 2.06
Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care (2003) 1.91
Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes. Diabetes Care (2005) 1.81
Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry (2004) 1.52
Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care (2004) 1.50
Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factor. Am J Med (2003) 1.43
Association of asthma control with health care utilization: a prospective evaluation. Am J Respir Crit Care Med (2002) 1.33
The coming of age of the metabolic syndrome. Diabetes Care (2003) 1.32
The Asthma Therapy Assessment Questionnaire (ATAQ) for children and adolescents. Dis Manag (2004) 1.28
Impact of recent fracture on health-related quality of life in postmenopausal women. J Bone Miner Res (2006) 1.28
Relational coordination among nurses and other providers: impact on the quality of patient care. J Nurs Manag (2010) 1.24
Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation. Diabetes Care (2003) 1.12
Using an asthma control questionnaire and administrative data to predict health-care utilization. Chest (2006) 1.12
Impact of telehealth on clinical outcomes in patients with heart failure. Clin Nurs Res (2008) 1.07
Contemporary analysis of secondary failure of successful sulfonylurea therapy. Endocr Pract (2007) 1.05
Assessment of asthma severity and asthma control in children. Pediatrics (2006) 1.03
Employer-paid nonmedical costs for patients with diabetes and end-stage renal disease. Prev Chronic Dis (2006) 1.02
Treatment effectiveness of inhaled corticosteroids and leukotriene modifiers for patients with asthma: an analysis from managed care data. Allergy Asthma Proc (2003) 1.02
End-stage renal disease-associated managed care costs among patients with and without diabetes. Diabetes Care (2004) 1.01
Treatment escalation and rise in HbA1c following successful initial metformin therapy. Diabetes Care (2006) 1.01
The impact of physician attitudes and beliefs on treatment decisions: lipid therapy in high-risk patients. Med Care (2006) 1.00
Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study. BMC Cardiovasc Disord (2004) 0.98
Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes. Patient Prefer Adherence (2013) 0.94
Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes. Health Qual Life Outcomes (2009) 0.94
A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitus. Diabetes Ther (2015) 0.92
Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion. J Diabetes Sci Technol (2009) 0.89
Examination of treatment pattern differences by race. Ment Health Serv Res (2003) 0.89
Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims. Clin Ther (2009) 0.88
Asthma control and patient satisfaction among early pediatric users of montelukast. J Asthma (2002) 0.85
RN work engagement in generational cohorts: the view from rural US hospitals. J Nurs Manag (2013) 0.84
Economic and clinical impact of inpatient diabetic hypoglycemia. Endocr Pract (2009) 0.84
Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings. Prev Chronic Dis (2005) 0.84
Use of telehealth by older adults to manage heart failure. Res Gerontol Nurs (2008) 0.84
Treatment of migraine with rizatriptan: when to take the medication. Headache (2002) 0.83
The use of self-generated identification codes in longitudinal research. Eval Rev (2008) 0.82
Trends in lipid management among patients with coronary artery disease: has diabetes received the attention it deserves? Diabetes Care (2003) 0.81
Population implications of changes in lipid management in patients with coronary heart disease. Am J Cardiol (2004) 0.81
Use of the UKPDS Outcomes Model to predict all-cause mortality in U.S. adults with type 2 diabetes mellitus: comparison of predicted versus observed mortality. Diabetes Res Clin Pract (2010) 0.81
Using the pediatric asthma therapy assessment questionnaire to measure asthma control and healthcare utilization in children. Patient (2009) 0.81
Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetes. BMC Endocr Disord (2012) 0.81
Why do some health centers provide more enabling services than others? J Health Care Poor Underserved (2009) 0.80
Patterns of asthma-related health care resource use in children treated with montelukast or fluticasone. Curr Med Res Opin (2006) 0.80
Projecting the effectiveness of RotaTeq® against rotavirus-related hospitalizations and deaths in six Asian countries. Hum Vaccin (2011) 0.80
Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline. Ann Allergy Asthma Immunol (2004) 0.80
Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practices. Am J Manag Care (2002) 0.79
The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathy. Pharmacoeconomics (2006) 0.78
Factors influencing the acceptance of changes in antiretroviral therapy among HIV-1-infected patients. AIDS Patient Care STDS (2007) 0.78
Comparative effectiveness analysis of amlodipine/renin-angiotensin system blocker combinations. J Clin Hypertens (Greenwich) (2012) 0.78
Managing heart failure patients after formal homecare. Telemed J E Health (2009) 0.77
Growth in use of lipid-lowering therapies: are we targeting the right patients? Am J Manag Care (2002) 0.77
Reassessment of cardiovascular risk in diabetes. Curr Opin Lipidol (2006) 0.77
Trends in lipid management among patients with diabetes. Endocr Pract (2006) 0.77
Asthma-related health care resource use among patients starting fluticasone or montelukast therapy. Pharmacotherapy (2005) 0.77
The Hyperlipidemia: Attitudes and Beliefs in Treatment (HABIT) survey for patients: results of a validation study. J Cardiovasc Nurs (2005) 0.77
Perception and management of fever in infants up to six months of age: a survey of US pediatricans. BMC Pediatr (2010) 0.76
Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease. Am J Cardiol (2005) 0.75
Reduction in Framingham risk of cardiovascular disease in obese patients undergoing laparoscopic adjustable gastric banding. Adv Ther (2013) 0.75
Health care utilization determined from administrative claims analysis for patients who received inhaled corticosteroids with either montelukast or salmeterol. J Manag Care Pharm (2006) 0.75
Does money really matter? The effects of fiscal margin on quality of care in military treatment facilities. Hosp Top (2007) 0.75
Asthma Severity in patients initiating controller monotherapy versus combination therapy. J Asthma (2011) 0.75
Macrovascular risk factors in patients with diabetes: physician treatment strategies and extent of control. Endocr Pract (2005) 0.75
Sensitization to common allergens in adults with asthma. J Am Board Fam Pract (2005) 0.75
Measuring staff nurse decisional involvement: the Decisional Involvement Scale. J Nurs Adm (2003) 0.75
The nursing practice environment in rural hospitals: Practice Environment Scale of the Nursing Work Index assessment. J Nurs Adm (2012) 0.75
Baseline management practices at providers in better jobs better care. Gerontol Geriatr Educ (2007) 0.75
Finance at the front line. The effects of financial slack on community health center clinical process quality. J Health Care Finance (2007) 0.75
The staff nurse decisional involvement scale: report of psychometric assessments. Nurs Res (2005) 0.75